Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Circulating levels of vitamin D, vitamin D receptor polymorphisms, and colorectal adenoma: a meta-analysis

  • Lee, Jung-Eun (Department of Food and Nutrition, Sookmyung Women's University)
  • Received : 2011.02.15
  • Accepted : 2011.06.23
  • Published : 2011.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Growing evidence suggests an elevated risk for colorectal neoplasia among individuals with low levels of vitamin D, the biological actions of which are mediated by the vitamin D receptor (VDR). To investigate the association among vitamin D status, VDR polymorphisms (FokI, and BsmI), and colorectal adenoma, we conducted a meta-analysis of nine studies of circulating levels of 25-hydroxyvitamin D (25(OH)D) and five studies of FokI or BsmI polymorphisms in relation to colorectal adenomas. Study-specific relative risks (RRs) and 95% confidence intervals (CIs) were pooled using a random-effects model. A total of 3398 coloreetal adenomas for 25(OH)D and 1754 colorectal adenomas for VDR were included in the meta-analysis. We identified a significant inverse association between colorectal adenoma (combined RR, 0.93; 95% CI, 0.87-0.98 per 10 ng/mL increase in 25(OH)D levels). When we examined FokI and BsmI polymorphisms in the meta-analysis, we found no association for either FokI (combined RR, 1.00; 95% CI, 0.95-1.06) or BsmI (combined RR, 0.99; 95% CI, 0.93-1.05) in the additive model. These data suggest an inverse association between circulating 25(OH)D levels and colorectal adenoma risk.

Keywords

References

  1. Lamprecht SA, Lipkin M. Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci 2001;952:73-87.
  2. Fraser DR. Biochemical and clinical aspects of vitamin D function. Br Med Bull 1981;37:37-42.
  3. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF. 25-hydroxyvitamin D-1alphahydroxylase in normal and malignant colon tissue. Lancet 2001;357:1673-4. https://doi.org/10.1016/S0140-6736(00)04831-5
  4. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A 1988;85:3294-8. https://doi.org/10.1073/pnas.85.10.3294
  5. Slattery ML. Vitamin D receptor gene (VDR) associations with cancer. Nutr Rev 2007;65:S102-4. https://doi.org/10.1301/nr.2007.aug.S102-S104
  6. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 2009;30:1170-80. https://doi.org/10.1093/carcin/bgp103
  7. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997;12:915-21. https://doi.org/10.1359/jbmr.1997.12.6.915
  8. Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996;11:1841-9.
  9. Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y, Koizumi A, Chihara J, Ogawa O, Kato T. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res 2000;60:305-8.
  10. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005;16:83-95. https://doi.org/10.1007/s10552-004-1661-4
  11. Fedirko V, Bostick RM, Goodman M, Flanders WD, Gross MD. Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol 2010;172:489-500. https://doi.org/10.1093/aje/kwq157
  12. Jacobs ET, Alberts DS, Benuzillo J, Hollis BW, Thompson PA, Martínez ME. Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J Steroid Biochem Mol Biol 2007;103:752-6. https://doi.org/10.1016/j.jsbmb.2006.12.039
  13. Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 2000;9:1059-65.
  14. Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA; Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004;13:546-52.
  15. Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, Sinha R. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2001;10:1267-74.
  16. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, Heber D. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71. https://doi.org/10.1093/jnci/djg110
  17. Levine AJ, Harper JM, Ervin CM, Chen YH, Harmon E, Xue S, Lee ER, Frankel HD, Haile RW. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 2001;39:35-41. https://doi.org/10.1207/S15327914nc391_5
  18. Takahashi R, Mizoue T, Otake T, Fukumoto J, Tajima O, Tabata S, Abe H, Ohnaka K, Kono S. Circulating vitamin D and colorectal adenomas in Japanese men. Cancer Sci 2010;101:1695-700. https://doi.org/10.1111/j.1349-7006.2010.01575.x
  19. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer 2007;109:510-7. https://doi.org/10.1002/cncr.22453
  20. Kim HS, Newcomb PA, Ulrich CM, Keener CL, Bigler J, Farin FM, Bostick RM, Potter JD. Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev 2001;10:869-74.
  21. Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control 2001;12:607-14. https://doi.org/10.1023/A:1011292002475
  22. Boyapati SM, Bostick RM, McGlynn KA, Fina MF, Roufail WM, Geisinger KR, Wargovich M, Coker A, Hebert JR. Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal antiinflammatory drug use? Cancer Epidemiol Biomarkers Prev 2003;12:631-7.
  23. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS; Members of UKCAP Consortium. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence. Int J Cancer 2008;123:586-93. https://doi.org/10.1002/ijc.23536
  24. Egan JB, Thompson PA, Ashbeck EL, Conti DV, Duggan D, Hibler E, Jurutka PW, Leroy EC, Martinez ME, Mount D, Jacobs ET. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res 2010;70:1496-504. https://doi.org/10.1158/0008-5472.CAN-09-3264
  25. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.
  26. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006;6:40-57.
  27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  28. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. https://doi.org/10.1136/bmj.315.7109.629
  29. Iseki K, Tatsuta M, Uehara H, Iishi H, Yano H, Sakai N, Ishiguro S. Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int J Cancer 1999;81:730-3. https://doi.org/10.1002/(SICI)1097-0215(19990531)81:5<730::AID-IJC11>3.0.CO;2-Q
  30. Sundaram S, Sea A, Feldman S, Strawbridge R, Hoopes PJ, Demidenko E, Binderup L, Gewirtz DA. The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res 2003;9:2350-6.
  31. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31. https://doi.org/10.1093/ije/9.3.227
  32. Lee JE, Li H, Chan AT, Hollis BW, Lee IM, Stampfer MJ, Wu K, Giovannucci E, Ma J. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) 2011;4:735-43. https://doi.org/10.1158/1940-6207.CAPR-10-0289
  33. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: a metaanalysis. Cancer Epidemiol Biomarkers Prev 2008;17:2958-69. https://doi.org/10.1158/1055-9965.EPI-08-0402
  34. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol 1993;137:1302-17.
  35. Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 2000;11:459-66. https://doi.org/10.1023/A:1008914108739
  36. Zheng W, Anderson KE, Kushi LH, Sellers TA, Greenstein J, Hong CP, Cerhan JR, Bostick RM, Folsom AR. A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:221-5.
  37. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 2002;94:437-46. https://doi.org/10.1093/jnci/94.6.437
  38. Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, Kim KM, Kim KJ, Rhee Y, Lim SK. Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 2011;96:643-51. https://doi.org/10.1210/jc.2010-2133
  39. Calvo MS, Whiting SJ. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003;61:107-13. https://doi.org/10.1301/nr.2003.marr.107-113
  40. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006;147:5542-8. https://doi.org/10.1210/en.2006-0946
  41. Kallay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 2002;40:1191-6. https://doi.org/10.1016/S0278-6915(02)00030-3
  42. Flugge J, Krusekopf S, Goldammer M, Osswald E, Terhalle W, Malzahn U, Roots I. Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol 2007;63:997-1005. https://doi.org/10.1007/s00228-007-0367-4
  43. Poynter JN, Jacobs ET, Figueiredo JC, Lee WH, Conti DV, Campbell PT, Levine AJ, Limburg P, Le Marchand L, Cotterchio M, Newcomb PA, Potter JD, Jenkins MA, Hopper JL, Duggan DJ, Baron JA, Haile RW. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010;19:525-36. https://doi.org/10.1158/1055-9965.EPI-09-0662
  44. Slatter ML, Yakumo K, Hoffman M, Neuhausen S. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control 2001;12:359-64. https://doi.org/10.1023/A:1011280518278
  45. Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, Slattery ML. Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 2006;15:744-9. https://doi.org/10.1158/1055-9965.EPI-05-0814
  46. Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP. Longterm variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2010;19:927-31. https://doi.org/10.1158/1055-9965.EPI-09-1121
  47. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004;15:255-65.
  48. Alberts DS, Martinez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P; Phoenix and Tucson Gastroenterologist Networks. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 2005;97:846-53. https://doi.org/10.1093/jnci/dji144
  49. Smith-Warner SA, Elmer PJ, Fosdick L, Randall B, Bostick RM, Grandits G, Grambsch P, Louis TA, Wood JR, Potter JD. Fruits, vegetables, and adenomatous polyps: the Minnesota Cancer Prevention Research Unit case-control study. Am J Epidemiol 2002;155:1104-13. https://doi.org/10.1093/aje/155.12.1104
  50. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB, Reid ME, Ritenbaugh C, Vargas PA, Bhattacharyya AB, Earnest DL, Sampliner RE. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 2000;342:1156-62. https://doi.org/10.1056/NEJM200004203421602

Cited by

  1. Vitamin D in acute stress and critical illness vol.15, pp.6, 2012, https://doi.org/10.1097/MCO.0b013e328358fc2b
  2. Vitamin D and Colorectal Cancer Prevention: A Review of Epidemiologic Studies vol.2, pp.1, 2013, https://doi.org/10.1007/s13668-012-0037-8
  3. Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants vol.120, pp.9, 2014, https://doi.org/10.1002/cncr.28565
  4. Gender- and site-specific differences of colorectal neoplasia relate to vitamin D vol.40, pp.11-12, 2014, https://doi.org/10.1111/apt.12981
  5. Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis vol.21, pp.29, 2015, https://doi.org/10.3748/wjg.v21.i29.8868
  6. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas vol.373, pp.16, 2015, https://doi.org/10.1056/NEJMoa1500409
  7. Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence vol.115, pp.09, 2016, https://doi.org/10.1017/S0007114516000696
  8. High Prevalence of Vitamin D Deficiency in Cambodian Women: A Common Deficiency in a Sunny Country vol.8, pp.5, 2016, https://doi.org/10.3390/nu8050290
  9. Prevalence of vitamin D insufficiency in radiologists: a cross-sectional study vol.47, pp.7, 2018, https://doi.org/10.1007/s00256-018-2896-6
  10. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women vol.8, pp.8, 2011, https://doi.org/10.1158/1940-6207.capr-14-0470
  11. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas vol.45, pp.1, 2011, https://doi.org/10.1093/ije/dyv185
  12. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal‐appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial vol.58, pp.4, 2011, https://doi.org/10.1002/mc.22945
  13. No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial vol.12, pp.5, 2019, https://doi.org/10.1158/1940-6207.capr-19-0023
  14. Vitamin D as a Potential Therapeutic Option in Cancer Treatment: Is There a Role for Chemoprevention? vol.20, pp.None, 2020, https://doi.org/10.2174/1871520620999200729192728
  15. Relationship between 25(OH)D and Colorectal Cancer Prevalence at Dr. Moewardi Hospital Surakarta-Indonesia: A Cross-Sectional Study vol.9, pp.2, 2011, https://doi.org/10.3889/oamjms.2021.7396
  16. Blunted PTH response to vitamin D insufficiency/deficiency and colorectal neoplasia risk vol.40, pp.5, 2021, https://doi.org/10.1016/j.clnu.2020.10.057